You searched for "products"
In conversation with Erwin Offeciers
Professor Erwin Offeciers is a renowned adult and paediatric otologist, living and working in Antwerp, Belgium. He has extensive experience in cochlear implantation and has also spearheaded the well described bony obliteration technique. He is to sit on the forthcoming...In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness
Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...Adult hearing screenings has counselling opportunities
Adult hearing screening has its challenges, particularly time constraints. Because the process itself is brief, we could efficiently screen dozens of adults per hour; at events such as health fairs, it’s tempting to march people through screenings as quickly as...HPV and ENT; should we vaccinate boys?
David Black and Charlie Hall reiterate Vin Paleri’s pleas for a common sense evidence-based approach by those who allocate healthcare resources to the now urgent issue of HPV-related disease. They discuss the merits of different vaccines and the need for...Head and neck cancer awareness
Head and neck cancer is one of the most preventable cancers, and awareness and screening campaigns have shown a decline in its incidence. Support for campaigns of awareness and education about these cancers is crucial from professional, societal and governmental...Training in Facial Plastic Surgery in the UK
Following the Keogh report earlier this year into the quality of cosmetic surgery in the UK, surgical training in cosmetic surgery is high on the agenda. A Cosmetic Surgery Interspecialty Committee at the Royal College of Surgeons is currently discussing...
Does Tranexamic acid reduce intraoperative bleeding during FESS?
Intraoperative bleeding during FESS can reduce visibility and obscure important landmarks. This can result in longer operative times, increase risks of complications and even lead to incomplete surgery. Tranexamic acid is a drug which prevents fibrinolysis and stabilises blood clots....Take part in the FAMOUS study
Could your clinic be one of 40 NHS sites across the UK to participate in the FAMOUS study? Organisers need your help to improve the assessment and management of adult hearing loss.The Hallpike Prize 2024
The Hallpike prize is awarded annually for the best project of the past 24 month period (research, audit or review of subject) in the area of audiovestibular medicine. The project can be unpublished, published or be in form of a presentation or poster, but the prize committee must be able to assess its quality from the available information provided within the application.The impact of hearing loss in children with Down syndrome
Hearing loss and language development Down syndrome (DS) usually arises due to trisomy 21 and is associated with intellectual disability and risks of developmental delays and difficulties, including hearing loss. Hearing loss is common in children with DS [1]. In...2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...
